Lifecore Biomedical Aktie
WKN: 899376 / ISIN: US5147661046
07.10.2014 23:00:52
|
Landec Q1 Profit Down
(RTTNews) - Landec Corp. (LNDC) Tuesday reported a profit for the first quarter that halved from last year, despite 22 percent revenue growth.
Net income for the quarter dropped to $2.35 million or $0.09 per share from $4.75 million or $0.18 per share last year. Analysts polled by Thomson Reuters expected earnings of $0.09 per share for the quarter. Analysts' estimates typically exclude one-time items.
The decrease in bottom line mainly reflects a $5.2 million decrease in the change in the fair market value of the company's Windset investment and a $1.2 million increase in the net loss at Lifecore from lower sales of higher margin fermentation products.
Consolidated revenues increased 22 percent to $133.6 million from $109.5 million last year, with Apio's value-added vegetable business up 26 percent and Apio's export business up 24 percent. Analysts had a consensus revenue estimate of $121.91 million for the quarter.
"For the first quarter, we exceeded both our revenue and operating income expectations because of positive operating results at Apio driven by sales increases in our higher margin vegetable salad kits and stir fry kits, which we collectively refer to as our superfood products," said CEO Gary Steele.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Lifecore Biomedicalmehr Nachrichten
11.04.25 |
NASDAQ Composite Index-Titel Lifecore Biomedical-Aktie: So viel Verlust hätte ein Investment in Lifecore Biomedical von vor einem Jahr bedeutet (finanzen.at) | |
09.04.25 |
Zuversicht in New York: So performt der NASDAQ Composite mittags (finanzen.at) | |
08.04.25 |
Gewinne in New York: NASDAQ Composite am Nachmittag mit Zuschlägen (finanzen.at) | |
08.04.25 |
Gute Stimmung in New York: NASDAQ Composite am Dienstagmittag im Aufwind (finanzen.at) | |
08.04.25 |
Optimismus in New York: NASDAQ Composite legt zum Handelsstart deutlich zu (finanzen.at) | |
04.04.25 |
Zurückhaltung in New York: NASDAQ Composite bricht schlussendlich ein (finanzen.at) | |
04.04.25 |
NASDAQ Composite aktuell: NASDAQ Composite bricht am Nachmittag ein (finanzen.at) | |
04.04.25 |
Schwache Performance in New York: NASDAQ Composite rauscht am Freitagmittag ab (finanzen.at) |
Analysen zu Lifecore Biomedicalmehr Analysen
Aktien in diesem Artikel
Lifecore Biomedical | 5,05 | -9,01% |
|